Arkadios Wealth Advisors Biogen Inc. Transaction History

Arkadios Wealth Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$193.77 - $244.14 $173,811 - $218,993	-897 Closed	0 $0
Q4 2021 Feb 03, 2022	SELL	$223.92 - $287.77 $110,616 - $142,158	-494 Reduced 35.51%	897 $215,000
Q3 2021 Oct 19, 2021	SELL	$282.99 - $369.05 $43,014 - $56,095	-152 Reduced 9.85%	1,391 $393,000
Q2 2021 Jul 28, 2021	BUY	$259.0 - $414.71 $86,506 - $138,513	334 Added 27.63%	1,543 $534,000
Q1 2021 Apr 26, 2021	BUY	$242.95 - $284.63 $23,809 - $27,893	98 Added 8.82%	1,209 $338,000
Q4 2020 Feb 09, 2021	BUY	$236.26 - $355.63 $235,078 - $353,851	995 Added 857.76%	1,111 $272,000
Q3 2020 Nov 10, 2020	SELL	$264.77 - $305.71 $529 - $611	-2 Reduced 1.69%	116 $32.5 Million
Q2 2020 Aug 10, 2020	BUY	$258.66 - $342.55 $6,207 - $8,221	24 Added 25.53%	118 $33.2 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $7,796 - $9,890	-29 Reduced 23.58%	94 $29.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $27,067 - $37,400	123 New	123 $36,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.